rhIL-7-hyFc, a long-acting interleukin-7, improves efficacy of CAR-T cell therapy in solid tumors is a research paper published in Journal for ImmunoTherapy of Cancer (2024). On theSindex it has a DataRank of 0. It has been cited 30 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Center for Cancer Research
Grant: CRADA with NeoImmuneTech, Inc.
Center for Cancer Research
Grant: Z01 BC010891
Center for Cancer Research
Grant: ZIA BC010891
National Institutes of Health
Grant: 1Z01BC010891-01
Antibody Therapy of Cancer
FWCI
5.51
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals